{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:11:18Z","timestamp":1793448678770,"version":"4.5.0"},"reference-count":32,"publisher":"BMJ","issue":"3","funder":[{"name":"This research was funded by the UK Department of Health, Northumbria NHS Foundation Trust TRF programme, Breathe North appeal, and Novartis Pharmaceuticals UK"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Emerg Med J"],"accepted":{"date-parts":[[2020,10,19]]},"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In hospitalised patients with exacerbation of Chronic Obstructive Pulmonary Disease, European and British guidelines endorse oxygen target saturations of 88%\u201392%, with adjustment to 94%\u201398% if carbon dioxide levels are normal. We assessed the impact of admission oxygen saturation level and baseline carbon dioxide on inpatient mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients were identified from the prospective Dyspnoea, Eosinopenia, Consolidation, Acidaemia and Atrial Fibrillation (DECAF) derivation study (December 2008\u2013June 2010) and the mixed methods DECAF validation study (January 2012 to May 2014). In six UK hospitals, of 2645 patients with COPD exacerbation, 1027 patients were in receipt of supplemental oxygen at admission. All had a clinical history of COPD and obstructive spirometry. These patients were subdivided into the following groups: admission oxygen saturations of 87% or less, 88%\u201392%, 93%\u201396% or 97%\u2013100%. Inpatient mortality was calculated for each group and expressed as ORs. The DECAF score and National Early Warning Score 2 (excluding oxygen saturation) were used in binary logistic regression to adjust for baseline risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In patients with COPD receiving supplemental oxygen, oxygen saturations above 92% were associated with higher mortality and an adverse dose\u2013response. Compared with the 88%\u201392%\u2009group, the adjusted risk of death (OR) in the 93%\u201396%\u2009and 97%\u2013100% groups was 1.98 (95% CI 1.09 to 3.60, p=0.025) and 2.97 (95% CI 1.58 to 5.58, p=0.001). In the subgroup with normocapnia, the mortality signal remained significant in both the 93%\u201396%\u2009and 97%\u2013100% groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Inpatient mortality was lowest in those with oxygen saturations of 88%\u201392%. Even modest elevations in oxygen saturations above this range (93%\u201396%) were associated with an increased risk of death. A similar mortality trend was seen in both patients with hypercapnia and normocapnia. This shows that the practice of setting different target saturations based on carbon dioxide levels is not justified. Treating all patients with COPD with target saturations of 88%\u201392%\u2009will simplify prescribing and should improve outcome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>UKCRN ID 14214.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/emermed-2019-209257","type":"journal-article","created":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T17:25:34Z","timestamp":1606411534000},"page":"170-177","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":63,"title":["Oxygen therapy and inpatient mortality in COPD exacerbation"],"prefix":"10.1136","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6916-8862","authenticated-orcid":false,"given":"Carlos","family":"Echevarria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Steer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Wason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Bourke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,11,26]]},"reference":[{"key":"2025062300402207000_38.3.170.1","unstructured":"The National Confidential Enquiry into Patient Outcome and Death . Inspiring Change. London, 2017. https:\/\/www.ncepod.org.uk\/2017report2\/downloads\/InspiringChange_FullReport.pdf"},{"key":"2025062300402207000_38.3.170.2","doi-asserted-by":"publisher","DOI":"10.3109\/15412555.2010.510157"},{"key":"2025062300402207000_38.3.170.3","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2010.153114"},{"key":"2025062300402207000_38.3.170.4","first-page":"717","article-title":"AARC Clinical Practice Guideline: oxygen therapy for adults in the acute care facility--2002 revision & update","volume":"47","author":"Kallstrom","year":"2002","journal-title":"Respir Care"},{"key":"2025062300402207000_38.3.170.5","doi-asserted-by":"publisher","DOI":"10.1111\/ijs.12551"},{"key":"2025062300402207000_38.3.170.6","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1016\/j.resuscitation.2015.07.043","article-title":"Part 5: acute coronary syndromes: 2015 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations","volume":"95","author":"Nikolaou","year":"2015","journal-title":"Resuscitation"},{"key":"2025062300402207000_38.3.170.7","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000000998"},{"key":"2025062300402207000_38.3.170.8","unstructured":"Moga C , Chojecki D . Oxygen therapy in acute care settings. Institute of Health Economics 2016."},{"key":"2025062300402207000_38.3.170.9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k4169"},{"key":"2025062300402207000_38.3.170.10","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2016-209729"},{"key":"2025062300402207000_38.3.170.11","unstructured":"Royal College of Physicians . National early warning score (NEWS) 2: standardising the assessment of acute-illness severity in the NHS. London; 2017."},{"key":"2025062300402207000_38.3.170.12","doi-asserted-by":"publisher","DOI":"10.1183\/20734735.025212"},{"key":"2025062300402207000_38.3.170.13","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00791-2016"},{"key":"2025062300402207000_38.3.170.14","unstructured":"GOLD . Global initiative for chronic obstructive lung disease; 2019."},{"key":"2025062300402207000_38.3.170.15","doi-asserted-by":"publisher","DOI":"10.1111\/resp.12620"},{"key":"2025062300402207000_38.3.170.16","first-page":"1241","article-title":"Oxygen therapy in acute exacerbations of chronic obstructive pulmonary disease","volume":"9","author":"Brill","year":"2014","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2025062300402207000_38.3.170.17","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.161.5.9904119"},{"key":"2025062300402207000_38.3.170.18","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-015-0084-6"},{"key":"2025062300402207000_38.3.170.19","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.014494"},{"key":"2025062300402207000_38.3.170.20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c5462"},{"key":"2025062300402207000_38.3.170.21","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30479-3"},{"key":"2025062300402207000_38.3.170.22","unstructured":"European Respiratory Society . An international comparison of COPD care in Europe, results of the first European COPD audit; 2012."},{"key":"2025062300402207000_38.3.170.23","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00042711"},{"key":"2025062300402207000_38.3.170.24","doi-asserted-by":"publisher","DOI":"10.1177\/1479972314562408"},{"key":"2025062300402207000_38.3.170.25","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2012-202103"},{"key":"2025062300402207000_38.3.170.26","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2015-207775"},{"key":"2025062300402207000_38.3.170.27","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2016-209298"},{"key":"2025062300402207000_38.3.170.28","doi-asserted-by":"publisher","DOI":"10.2307\/2291635"},{"key":"2025062300402207000_38.3.170.29","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1177\/1471082X17697749","article-title":"Mean-parametrized Conway\u2013Maxwell\u2013Poisson regression models for dispersed counts","volume":"17","author":"Huang","year":"2017","journal-title":"Stat Modelling"},{"key":"2025062300402207000_38.3.170.30","doi-asserted-by":"publisher","DOI":"10.7326\/M16-2607"},{"key":"2025062300402207000_38.3.170.31","unstructured":"Stone RA , Holzhauer-Barrie J , Lowe D . COPD: who cares matters. National chronic obstructive pulmonary disease (COPD) audit programme: clinical audit of COPD exacerbations admitted to acute units in England and Wales 2014 2015."},{"key":"2025062300402207000_38.3.170.32","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S2213-2600(17)30046-2","article-title":"Hyperoxia and hypertonic saline in patients with septic shock (HYPERS2S): a two-by-two factorial, multicentre, randomised, clinical trial","volume":"5","author":"Asfar","year":"2017","journal-title":"Lancet Respir Med"}],"container-title":["Emergency Medicine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/emermed-2019-209257","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T03:40:55Z","timestamp":1750650055000},"score":1,"resource":{"primary":{"URL":"https:\/\/emj.bmj.com\/lookup\/doi\/10.1136\/emermed-2019-209257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,26]]},"references-count":32,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,2,22]]},"published-print":{"date-parts":[[2021,3]]}},"alternative-id":["10.1136\/emermed-2019-209257"],"URL":"https:\/\/doi.org\/10.1136\/emermed-2019-209257","relation":{},"ISSN":["1472-0205","1472-0213"],"issn-type":[{"value":"1472-0205","type":"print"},{"value":"1472-0213","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,26]]}}}